W. Bergmeier et al., Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies, BLOOD, 95(3), 2000, pp. 886-893
Five novel monoclonal antibodies (mAbs; p0p 1-5) were used to characterize
the structural and functional properties and the in vivo expression of the
murine GPIb-IX complex (von Willebrand factor receptor). The molecular weig
hts of the subunits are similar to the human homologs: GPIb alpha (150 kd),
GPIb beta (25 kd), and GPIX (25 kd). Activation of platelets with thrombin
or PMA predominantly induced shedding of glycocalicin (GC; 130 kd) but onl
y low levels of receptor internalization. The GC concentration in normal mo
use plasma was found to be at least 10 times higher than that described for
human plasma (approximately 25 mu g/mL versus 1-2 mu g/mL), Two additional
cleavage sites for unidentified platelet-derived proteases were found on G
PIb alpha; as demonstrated by the generation of 3 N-terminal fragments duri
ng in vitro incubation of washed platelets (GC, 60 kd, 45 kd). Occupancy of
GPIb alpha with p0p mAbs or F(ab)(2)-fragments resulted in aggregate forma
tion in vitro and rapid irreversible thrombocytopenia in vivo, irrespective
of the exact binding epitopes of the individual antibodies. GPIb-IX was no
t detectable immunohistochemically on endothelial cells In the major organs
under normal or inflammatory conditions. The authors conclude that the mou
se system might become an Interesting model for studies on GPIb-IX function
and regulation.
(C) 2000 by The American Society of Hematology.